Skip to main content
Equibles

Dana Investment Advisors, Inc.

Position in VKTX — Viking Therapeutics, Inc.

CIK 1427514 BROOKFIELD, WI
Back to VKTX Full portfolio

Position in VKTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,256,884
+$312,424 QoQ
Shares Held
57,854
-3.2% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#112
of 436 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Dana Investment Advisors, Inc. holds $43,128,971 across 12 Biotechnology names. VKTX ranks #5 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LGND
Ligand Pharmaceuticals Inc
 57,520 $18,181,496
2 AXSM
Axsome Therapeutics, Inc.
 22,850 $5,592,994
3 REGN
Regeneron Pharmaceuticals, Inc.
 7,719 $4,813,105
4 TGTX
Tg Therapeutics, Inc.
 42,012 $2,308,139
5 VKTX
Viking Therapeutics, Inc.
This page 		57,854 $2,256,884
6 MDGL
Madrigal Pharmaceuticals, Inc.
 3,677 $1,974,365
7 ZYME
Zymeworks Inc.
 71,660 $1,873,192
8 IONS
Ionis Pharmaceuticals Inc
 23,272 $1,845,236

All Filings in VKTX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,256,884 57,854
2026-03-31 $1,944,460 59,756
2025-12-31 $1,969,833 55,993
2025-09-30 $1,734,059 65,984
2025-06-30 $1,202,808 45,389
2025-03-31 $462,520 19,152
2024-12-31 $674,060 16,751
2024-09-30 $1,257,336 19,860
2024-06-30 $527,078 9,943
2024-03-31 $237,882 2,901